Miromatrix Medical Inc. (MIRO)
NASDAQ: MIRO
· Real-Time Price · USD
3.39
0.02 (0.59%)
At close: Dec 12, 2023, 10:00 PM
Miromatrix Medical Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -27.41M | -28.58M | -30.24M | -29.96M | -28.49M | -25.92M | -21.44M | -14.67M | -10.28M | -8.22M | -7.79M |
Depreciation & Amortization | 1.16M | 1.15M | 1.14M | 1.11M | 892.12K | 645.24K | 400.77K | 167.91K | 124.02K | 124.52K | 132.46K |
Stock-Based Compensation | 1.23M | 1.16M | 1.15M | 1.15M | 1.09M | 983.2K | 822.69K | 622.16K | 556.96K | 569.39K | 620.91K |
Other Working Capital | 1.48M | 1.6M | 1.75M | 587.35K | 1.46M | 1.28M | 1.65M | 372.05K | 1.05M | 1.45M | 949.68K |
Other Non-Cash Items | 281.35K | -185.11K | -325.86K | -70.47K | 48.31K | -14.09K | 73.17K | -2.37M | -3.86M | -3.29M | -2.7M |
Deferred Income Tax | -218.14K | -100.7K | n/a | n/a | 5.46K | 5.46K | -47.53K | -2.52M | -3.91M | -3.41M | -2.83M |
Change in Working Capital | 646.41K | -18.19K | 406.4K | 1.09M | -767K | 1.1M | 83.39K | 1.44M | 3.31M | 1.44M | 1.59M |
Operating Cash Flow | -24.31M | -26.58M | -27.87M | -26.68M | -27.23M | -23.21M | -20.06M | -14.81M | -10.15M | -9.37M | -8.14M |
Capital Expenditures | -239.63K | -364.08K | -465.06K | -1.06M | -2.79M | -4.03M | -3.99M | -3.38M | -1.45M | -93.84K | -122.1K |
Cash Acquisitions | 3.74M | 3.74M | n/a | n/a | n/a | n/a | n/a | 2M | 5M | 5M | 5M |
Purchase of Investments | -35.77M | -35.77M | -26.03M | -26.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 26M | 20M | 14M | 6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 22.28M | 22.28M | n/a | n/a | -26.03M | -26.03M | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 16.02M | 9.89M | -12.49M | -21.09M | -28.82M | -30.05M | -3.99M | -1.38M | 3.55M | 4.91M | 4.88M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -223.94K | -223.94K | -17.98K | -3.35K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -441.35K | -441.35K | -14.63K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 9.31M | 9.1M | 9.31M | 168.34K | 293.42K | 131.79K | 65.27M | 65.36M | 65.13M | 65.35M | 327.1K |
Financial Cash Flow | 8.87M | 8.66M | 9.3M | 168.34K | 293.42K | 131.79K | 65.27M | 65.36M | 65.13M | 65.35M | 327.1K |
Net Cash Flow | 578.27K | -8.02M | -31.06M | -47.6M | -55.75M | -53.13M | 41.22M | 49.17M | 58.53M | 60.88M | -2.94M |
Free Cash Flow | -24.55M | -26.94M | -28.34M | -27.75M | -30.02M | -27.24M | -24.05M | -18.19M | -11.6M | -9.47M | -8.27M |